This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Akorn: the Pharmaceutical Stock You Can’t Afford to Ignore

Stocks in this article: AKRX

NEW YORK (TheStreet) -- A San Diego-based biopharmaceutical company is gaining international attention for an experimental Ebola treatment that just saved two lives.

Mapp Biopharmaceutical is that company. Although it might sound like it employs hundreds, it actually employs only nine.

It shipped three vials containing an experimental Ebola drug to two American aid workers in Liberia. It was a last-ditch effort to save their lives while their families were making funeral arrangements back in the U.S. Fortunately, those funerals were canceled.

Read More: Pandora's Got Static and Has Lost 53% of Its Market Share in 6 Months

I know what you may be thinking: What’s the ticker symbol for Mapp Biopharmaceutical? Well, unfortunately Mapp Biopharmaceuticals is not a publicly traded company; it is privately held.

But let’s hear it for the biotech and pharma stocks. These past two to three years have brought some amazing advances in the field of drug discovery and therapeutic medicine.

Drug stocks continue to be one of the best areas in the market. One name that I continue to own in my Aggressive Growth Account is Akorn (AKRX). And this company is actually public, though you may not know much about it.

Akorn, based in Lake Forest, Ill., is a niche generic pharmaceutical company that develops and markets pharmaceuticals in the areas of ophthalmology, hospital drugs and injectables. Stocks like this have been big winners in the past six months. Akorn in particular ranks as a Gunderson Trophy Winner, making it rare and mighty. I have only 10 Trophy Winner stocks in my 3,850 stock universe.

Let’s examine what makes Akorn a Trophy Winner at Gunderson Capital Management:

Data from Best Stocks Now App

Read More: How Wall Street Tobacco Deals Left States With Billions in Toxic Debt

Akorn has a market cap of $3.6 billion. Back in 2010, Akorn traded at $1 per share. Today the stock is at $37 per share. While Akorn may not be a mighty oak quite yet, it is well on its way.

Data from Best Stocks Now App

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,765.37 -12.78 -0.07%
S&P 500 2,062.80 +1.57 0.08%
NASDAQ 4,750.9320 +2.5360 0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs